KALV logo

KalVista Pharmaceuticals (KALV) Short Term Debt

Annual Short Term Debt

$1.30 M
+$215.00 K+19.78%

30 April 2024

KALV Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$1.26 M
-$38.00 K-2.92%

31 July 2024

KALV Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KALV Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+19.8%+10.1%
3 y3 years+50.9%+35.9%
5 y5 years+100.0%+110.0%

KALV Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+50.9%-2.9%+35.9%
5 y5 yearsat high-2.9%+199.5%
alltimeall time-70.6%-80.8%

KalVista Pharmaceuticals Short Term Debt History

DateAnnualQuarterly
July 2024
-
$1.26 M(-2.9%)
Apr 2024
$1.30 M(+19.8%)
$1.30 M(+9.7%)
Jan 2024
-
$1.19 M(+3.4%)
Oct 2023
-
$1.15 M(+2.3%)
July 2023
-
$1.12 M(+3.2%)
Apr 2023
$1.09 M(+11.3%)
$1.09 M(+2.8%)
Jan 2023
-
$1.06 M(+3.0%)
Oct 2022
-
$1.03 M(+2.9%)
July 2022
-
$997.00 K(+2.0%)
Apr 2022
-
$977.00 K(-3.6%)
Apr 2022
$977.00 K(+13.2%)
-
Jan 2022
-
$1.01 M(+9.0%)
Oct 2021
-
$930.00 K(+2.8%)
July 2021
-
$905.00 K(+4.9%)
Apr 2021
$863.00 K(+46.8%)
$863.00 K(+45.8%)
Jan 2021
-
$592.00 K(+40.3%)
Oct 2020
-
$422.00 K(-17.7%)
July 2020
-
$513.00 K(-12.8%)
Apr 2020
$588.00 K
$588.00 K(-0.7%)
DateAnnualQuarterly
Jan 2020
-
$592.00 K(-1.7%)
Oct 2019
-
$602.00 K(+3.8%)
July 2019
-
$580.00 K(>+9900.0%)
Apr 2019
$0.00(-100.0%)
$0.00(-100.0%)
Jan 2019
-
$109.00 K(-30.6%)
Oct 2018
-
$157.00 K(-26.6%)
July 2018
-
$214.00 K(-3.2%)
Apr 2018
$221.00 K(-84.8%)
$221.00 K(-0.5%)
Jan 2018
-
$222.00 K(+0.9%)
Oct 2017
-
$220.00 K(+8.9%)
July 2017
-
$202.00 K(-89.6%)
Mar 2016
-
$1.95 M(+34.0%)
Dec 2015
$1.46 M(-67.2%)
$1.46 M(+50.8%)
Sept 2015
-
$965.00 K(+101.0%)
June 2015
-
$480.00 K(-92.7%)
Mar 2015
-
$6.60 M(+48.8%)
Dec 2014
$4.43 M(+44.8%)
$4.43 M(+1.0%)
Sept 2014
-
$4.39 M(+43.3%)
Dec 2013
$3.06 M(+14.1%)
$3.06 M
Dec 2012
$2.69 M
-

FAQ

  • What is KalVista Pharmaceuticals annual short term debt?
  • What is the all time high annual short term debt for KalVista Pharmaceuticals?
  • What is KalVista Pharmaceuticals annual short term debt year-on-year change?
  • What is KalVista Pharmaceuticals quarterly short term debt?
  • What is the all time high quarterly short term debt for KalVista Pharmaceuticals?
  • What is KalVista Pharmaceuticals quarterly short term debt year-on-year change?

What is KalVista Pharmaceuticals annual short term debt?

The current annual short term debt of KALV is $1.30 M

What is the all time high annual short term debt for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high annual short term debt is $4.43 M

What is KalVista Pharmaceuticals annual short term debt year-on-year change?

Over the past year, KALV annual short term debt has changed by +$215.00 K (+19.78%)

What is KalVista Pharmaceuticals quarterly short term debt?

The current quarterly short term debt of KALV is $1.26 M

What is the all time high quarterly short term debt for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high quarterly short term debt is $6.60 M

What is KalVista Pharmaceuticals quarterly short term debt year-on-year change?

Over the past year, KALV quarterly short term debt has changed by +$116.00 K (+10.10%)